Health Assessment Study (0954-946)

Organon and Co143 enrolled

Overview

The study will look at the effects of losartan or atenolol on frequency of sexual intercourse in subjects with newly diagnosed mild to moderate hypertension.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

143

Conditions

Hypertension

Interventions

MK0954, /Duration of Treatment : 16 WeeksDRUG

Comparator : atenolol /Duration of Treatment : 16 WeeksDRUG

Eligibility

Sex: MALEMin age: 40 YearsMax age: 49 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Newly diagnosed with mild to moderate hypertension\\ * Married male in stable heterosexual relationship * No prior history of sexual dysfunction * Satisfied with overall sex life * Patient's spouse is in close proximity for the study * Has had at least 2 but not more than 10 sexual intercourse events during the 2 week period prior to study start * Patient able to visit doctor in the morning of each scheduled visit * Able to complete the self administered health assessment questionnaire Exclusion Criteria: * Hypertension due to cancer, history of heart or circulatory problems * History of mental disorder that might impair sexual function * History or presence of drug or alcohol abuse * Prior surgery for erectile dysfunction or other urological procedure * No penile implant or assist devices * History of chronic liver disease, history of diabetes * History of severe life-threatening diseases such as, cancer, AIDS or positive HIV test * Subjects with only 1 kidney * Mental handicap or legal incapacity

Outcomes

Primary Outcomes

number of sexual intercourse events in a 2-week period

Time frame: 2 Weeks

Secondary Outcomes

sexual functioning score and overall sexual satisfaction score after 16 weeks

Time frame: 16 Weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.